Majó G, Ferrer I, Marsal J, Blasi J, Aguado F
Departament de Biologia Cellular i Anatomia Patològica, Universitat de Barcelona, Spain.
J Pathol. 1997 Dec;183(4):440-6. doi: 10.1002/(SICI)1096-9896(199712)183:4<440::AID-PATH953>3.0.CO;2-#.
SNAP-25 and Rab3A were originally identified as synaptic proteins involved in neuronal membrane traffic. Recently, both proteins have been detected in several mammalian endocrine cell types and have been proposed as essential components of the exocytotic pathway in neuroendocrine cells. In this study, the expression of SNAP-25 and Rab3A was analysed in biopsied human anterior pituitary tumours (21 cases) by immunocytochemical methods. No differences in Rab3A immunoreactivity were observed between tumour and normal pituitary cells. Strong SNAP-25 immunoreactivity was detected in tumour cells of prolactinomas (n = 3). Several growth hormone (GH)/prolactin (PRL) tumours also displayed intense SNAP-25 immunolabelling (n = 3), whereas the remaining GH-secreting adenomas (n = 4) exhibited moderate to weak SNAP-25 immunoreactivity. In contrast, SNAP-25 near-background immunostaining was observed in tumour cells of adrenocorticotrophic hormone (ACTH)-secreting tumours (n = 4) and non-secreting tumours (n = 7), as well as in normal pituitary cells. Since SNAP-25 and Rab3A have been shown to be involved in exocytotic events in rodent endocrine cells, overexpression of SNAP-25 protein in PRL and GH/PRL tumour cells might be implicated in the mechanism of exocytosis of the neoplastic human mammosomatotroph lineages.
SNAP-25和Rab3A最初被鉴定为参与神经元膜运输的突触蛋白。最近,这两种蛋白在几种哺乳动物内分泌细胞类型中均被检测到,并被认为是神经内分泌细胞胞吐途径的重要组成部分。在本研究中,采用免疫细胞化学方法分析了21例经活检的人垂体前叶肿瘤中SNAP-25和Rab3A的表达情况。肿瘤细胞与正常垂体细胞之间未观察到Rab3A免疫反应性的差异。在催乳素瘤(n = 3)的肿瘤细胞中检测到强SNAP-25免疫反应性。几例生长激素(GH)/催乳素(PRL)肿瘤也显示出强烈的SNAP-25免疫标记(n = 3),而其余分泌GH的腺瘤(n = 4)表现出中度至弱的SNAP-25免疫反应性。相比之下,在促肾上腺皮质激素(ACTH)分泌肿瘤(n = 4)和无分泌功能肿瘤(n = 7)的肿瘤细胞以及正常垂体细胞中观察到SNAP-25接近背景的免疫染色。由于SNAP-25和Rab3A已被证明参与啮齿动物内分泌细胞的胞吐事件,PRL和GH/PRL肿瘤细胞中SNAP-25蛋白的过表达可能与人类乳腺生长激素细胞系肿瘤细胞的胞吐机制有关。